ACTIVE

EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result103,9 k €-72,0 %over 1 year

Gross margin1,9 M €-21,6 %over 1 year

Equity816,3 k €0,0 %over 1 year

Workforce20,0 ETP-9,1 %over 1 year

Identity

Source · BCE/KBO

EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM is a Public limited company incorporated in 1988. Its main activity is: Technical testing and analysis. Its registered office is in Brugge. It employs on average 20,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0435.237.515
Incorporation: 09/09/1988
Legal form: Public limited company
Registered office: Lieven Bauwensstraat 6
8200 Brugge · FlandreSee on map
Contributed capital: 445 000,00 €
Latest accounts: 31/12/2025
Average workforce: 20,0 ETP

Activities (NACE)

71209Technical testing and analysis· main 71209Technical testing and analysis 72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering 73100Advertising 74302Translation and interpretation activities

Joint committees (7)

100
116
207
218
305
30502
330

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	1,9 M €	-21.6%	2,4 M €	-21.0%	3,1 M €	+15.4%	2,6 M €	+32.6%	2 M €
EBITDA	316,3 k €	-54.3%	692,5 k €	-51.3%	1,4 M €	+4.0%	1,4 M €	+52.5%	896,2 k €
Operating result	223,1 k €	-61.1%	574,2 k €	-22.0%	736,5 k €	-38.3%	1,2 M €	+64.8%	724,4 k €
Net result	103,9 k €	-72.0%	371 k €	-18.8%	457,1 k €	-44.4%	822,7 k €	+63.7%	502,7 k €
Balance sheet
Equity	816,3 k €	0.0%	816,3 k €	0.0%	816,3 k €	0.0%	816,3 k €	0.0%	816,3 k €
Total assets	3,2 M €	-8.3%	3,5 M €	-8.2%	3,8 M €	-23.7%	5 M €	+33.4%	3,8 M €
Cash	677,2 k €	-19.9%	845,3 k €	+66.4%	507,9 k €	+93.2%	262,9 k €	-10.7%	294,3 k €
Debts	2,4 M €	-7.2%	2,6 M €	-11.3%	2,9 M €	-30.1%	4,2 M €	+43.3%	2,9 M €
Other
Workforce	20,0 ETP	-9.1%	22,0 ETP	-3.1%	22,7 ETP	+14.1%	19,9 ETP	+4.2%	19,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 14 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Marco Antonio Baeli	Director28/04/2020 → 23/06/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Ronaldo Steentjes	Director01/03/2021 → 2024 accounts
An Pauwels	Managing director28/04/2017 → 2020 accounts
Berthold Hackl	Director19/08/2015 → 2020 accounts

Other companies at this address

Lieven Bauwensstraat 6 8200 Brugge

Company	CBE no.
EUROFINS FORENSICS BELGIUM● Active	0840.699.592
Eurofins NSC Belgium● Active	0822.018.283
Villers le Bouillet Rue le Marais Real Estate● Active	0670.803.203

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/07/2026	30/06/2025	10/07/2024	10/07/2023	01/07/2022	07/07/2021
General meeting	23/06/2026	11/06/2025	12/06/2024	14/06/2023	08/06/2022	28/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/06/2026	17/07/2026	Dutch	PDF
Abridged model	31/12/2024	11/06/2025	30/06/2025	Dutch	PDF
Abridged model	31/12/2023	12/06/2024	10/07/2024	Dutch	PDF
Abridged model	31/12/2022	14/06/2023	10/07/2023	Dutch	PDF
Abridged model	31/12/2021	08/06/2022	01/07/2022	Dutch	PDF
Abridged model	31/12/2020	28/06/2021	07/07/2021	Dutch	PDF
Abridged model	31/12/2019	29/07/2020	29/10/2020	Dutch	PDF
Abridged model	31/12/2018	27/06/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	18/05/2018	24/05/2018	Dutch	PDF
Abridged model	31/12/2016	28/04/2017	03/05/2017	Dutch	PDF
Full model	31/12/2015	12/07/2016	27/07/2016	Dutch	PDF
Full model	31/12/2014	18/06/2015	15/07/2015	Dutch	PDF
Full model	31/12/2013	22/08/2014	27/08/2014	Dutch	PDF
Full model	31/12/2012	28/06/2013	22/07/2013	Dutch	PDF
Full model	31/12/2011	13/06/2012	03/07/2012	Dutch	PDF
Abridged model	31/03/2011	14/09/2011	03/11/2011	Dutch	PDF
Abridged model	31/03/2010	08/09/2010	29/10/2010	Dutch	PDF
Abridged model	31/03/2009	09/09/2009	26/10/2009	Dutch	PDF
Abridged model	31/03/2008	10/09/2008	24/11/2008	Dutch	PDF
Abridged model	31/03/2007	12/09/2007	15/10/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 14 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Marco Antonio Baeli	Director28/04/2020 → 23/06/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Ronaldo Steentjes	Director01/03/2021 → 2024 accounts
An Pauwels	Managing director28/04/2017 → 2020 accounts
Berthold Hackl	Director19/08/2015 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates07/07/2026
Ontslag bestuurder à Vo: , et
PDF
Mandates15/09/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/06/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/11/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/08/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/06/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/05/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/06/2017
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings17 filings

Mandates

Marco Antonio Baeli

Ronaldo Steentjes

An Pauwels

Berthold Hackl

Marcel Oerlemans

Gautier DE COCK

Isabelle Decroos

David BESNAULT

Frederic Dupont

Lieven DEWISPELAERE

Dirk BONTRIDDER

Jan CORDONNIER

Show the 3 other mandates

198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUMCHEMIPHAR

Lieven Bauwensstraat 6, 8200 Sint-Andries

Director

Managing director

Director

Vice-chairman of the board of directorsDirector

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Lieven Bauwensstraat 6, 8200 Sint-AndriesCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00304712

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUMCurrent	accounts 2012 → 2025	Accounts 2025 · 2026-00304712
CHEMIPHAR	accounts 2007 → 2011	Accounts 2011 · 2012-24100521

Events

2025
Annual accounts 2025103,9 k €↓
2024
Annual accounts 2024371 k €↓
2023
Annual accounts 2023457,1 k €↓
2022
Annual accounts 2022822,7 k €↑
2021
Annual accounts 2021502,7 k €↑
2018
Annual accounts 2018227,9 k €↑
2017
Annual accounts 2017214,7 k €↑
2016
Annual accounts 2016165,5 k €↑
2015
Annual accounts 201556,1 k €↑
2013
Annual accounts 2013-329,6 k €↓
2012
Annual accounts 2012-242,7 k €↓
2012
Name changeEUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM
2011
Annual accounts 2011290,3 k €↑
2011
Annual accounts 2011248,3 k €↑
2010
Annual accounts 2010181,8 k €↑
2009
Annual accounts 2009-11,3 k €↑
2008
Annual accounts 2008-42,1 k €↓
2007
Annual accounts 200722,1 k €
09/09/1988
IncorporationPublic limited company

EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events